Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Drugs of Today (Barcelona, Spain : 1998)|June 6, 2009
Potential microbial origins of schizophrenia and their treatmentsS Hossein FatemiSchizophrenia Bulletin|February 19, 2009
The neurodevelopmental hypothesis of schizophrenia, revisitedS Hossein Fatemi, Timothy D FolsomNeuropharmacology|September 18, 2012
The involvement of Reelin in neurodevelopmental disordersTimothy D Folsom, S Hossein FatemiSchizophrenia Research|November 30, 2014
GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autismS Hossein Fatemi, Timothy D FolsomMolecular Autism|May 10, 2011
Dysregulation of fragile × mental retardation protein and metabotropic glutamate receptor 5 in superior frontal cortex of individuals with autism: a postmortem brain studyS Hossein Fatemi, Timothy D FolsomProgress in Neuro-Psychopharmacology & Biological Psychiatry|February 22, 2012
Viral infection, inflammation and schizophreniaRachel E Kneeland, S Hossein FatemiAnatomical Record (Hoboken, N.J. : 2007)|September 9, 2011
Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implicationsGene J Blatt, S Hossein FatemiNeuropharmacology|November 27, 2010
The role of fragile X mental retardation protein in major mental disordersS Hossein Fatemi, Timothy D FolsomCellular and Molecular Neurobiology|February 18, 2004
Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjectsMohsen Araghi-Niknam, S Hossein FatemiSchizophrenia Research|November 25, 2004
GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellumS Hossein Fatemi, S Hossein Fatemi, Joel M Stary, et al.Pageof 6